Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery

Aptar and Massachusetts General Hospital announced a collaboration to develop a predictive, data-driven platform for advancing nose-to-brain drug delivery. The initiative could support more efficient development of treatments requiring central nervous system delivery, but no financial terms, timelines, or clinical data were disclosed.